DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

Dendreon Corp (NASDAQ: DNDN)

company name or ticker
Company Photos
(Click to zoom)

Dendreon: Time To Answer Questions

Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics

A Lesson Learned: The Unfortunate Case Of GT Advanced Technologies

The 1 Biotech Stock I'm Definitely Not Buying

Three of our analysts chime in on which biotech stocks they think are the most risky.

Cheap Stocks Wall Street Loves: Medivation

Medivation stock is up more than 1,000% over the past three years and yet is still considered a cheap stock when using this Wall Street metric. Find out why Wall Street has fallen in love with Medivation, and whether or not the stock can head higher.

Why Northwest Biotherapeutics Inc. Stock Skyrocketed 36% in 2014

Northwest Biotherapeutics stock has soared this year on the heels of three catalysts. Find out what those catalysts are and whether or not NW Bio still has legs.

Dendreon Short Interest Hits Critical Point

Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape

Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape

Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious

Why Inovio Pharmaceuticals Inc. Plunged By 10% in 2014

Cancer immunotherapy vaccine developer Inovio Pharmaceuticals has largely underperformed the market in 2014. Find out what's keeping the stock down and whether or not Inovio shares are poised for a rebound.
See More Articles...